Contract facts
FederalContractor Shall Perform Real Estate Portfolio Management & Workplace Strategy 2023. Period of Performance September 25… is a federal award for Pbs R11 Special Programs Fda 80 Branch held by M. Arthur Gensler Jr. & Associates, Inc. Estimated value $2.1M ($2.1M obligated). Current period of performance ends Sep 27, 2027 (potential Sep 27, 2028). Last award drew 1 bidder. Place of performance: WASHINGTON DC. Related solicitation 47PM1123R0030.
Contractor shall perform real estate portfolio management & workplace strategy 2023. period of performance september 25, 2023 thru septmber 30, 2024. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 27, 2027 (339 days remaining). Agencies typically plan 12–18 months ahead — at 11.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 47PM1123F0013? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordM. Arthur Gensler Jr. & Associates, Inc — $16.3M obligated across 28 awards (firm-wide, all agencies) · lead buyer Department of State (DOS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 47PM1123F0013?
47PM1123F0013 (Contractor shall perform real estate portfolio) is a Pbs R11 Special Programs Fda 80 Branch award with a potential value of $2.1M, currently held by M. Arthur Gensler Jr. & Associates, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 47PM11-23-F-0013?
47PM11-23-F-0013 is the dashed form of PIID 47PM1123F0013 (Contractor shall perform real estate portfolio), held by M. Arthur Gensler Jr. & Associates, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 47PM1123F0013?
Pbs R11 Special Programs Fda 80 Branch awarded 47PM1123F0013 to M. Arthur Gensler Jr. & Associates, Inc (potential $2.1M).
Who is the incumbent on 47PM1123F0013?
M. Arthur Gensler Jr. & Associates, Inc is the incumbent with $16.3M across 28 related awards in SCOUT’s public footprint. The current period of performance ends Sep 27, 2027.
When does M. Arthur Gensler Jr. & Associates, Inc’s 47PM1123F0013 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 27, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 47PM1123F0013? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.